140 filings
Page 3 of 7
8-K
sj5rgm
10 Nov 22
Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:01pm
8-K
e7fhbn
17 Oct 22
Regulation FD Disclosure
6:07am
8-K
k6ru52qoy
10 Aug 22
Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update
4:38pm
8-K
mxmqgy23qq0v0ji2
8 Jul 22
Submission of Matters to a Vote of Security Holders
4:00pm
DEFA14A
i4x2 4z39s1taoh8d
2 May 22
Additional proxy soliciting materials
5:17pm
PRE 14A
4q9gp
21 Apr 22
Preliminary proxy
9:00pm
8-K
4v7fb
24 Mar 22
Index to Consolidated Financial Statements
7:42am
S-8
moxlqox
24 Mar 22
Registration of securities for employees
7:36am
8-K
15ccpq9g9f7gitp81hww
16 Feb 22
Milestone Pharmaceuticals Announces Appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer
7:37am
EFFECT
z1gjk 1h1sieer
3 Feb 22
Notice of effectiveness
12:15am
CORRESP
m0a8u7s9e860j5
31 Jan 22
Correspondence with SEC
12:00am
UPLOAD
eceo pa00b
19 Nov 21
Letter from SEC
12:00am
8-K
0vbj390ggf
12 Nov 21
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
7:38am